Autoimmune Thyroiditis Shifting from Hashimoto's Thyroiditis to Graves' Disease
- PMID: 37109715
- PMCID: PMC10141468
- DOI: 10.3390/medicina59040757
Autoimmune Thyroiditis Shifting from Hashimoto's Thyroiditis to Graves' Disease
Abstract
In 15-20% of cases, Graves' disease (GD) shifts to Hashimoto's thyroiditis (HT), while the shift from HT to GD is rare. We present a case of a patient in whom HT shifted to GD, along with a literature review. A 50-year-old woman with myxedema was diagnosed with Hashimoto's disease due to hypothyroidism and the presence of antibodies against thyroid peroxidase (TPOAb) and thyroglobulin (TgAb); she also had thyroid stimulating antibodies (TSAb) without any signs of GD. Although thyroid hormone replacement therapy improved her thyroid function, 2 months later, hyperthyroidism appeared and did not improve after discontinuation of the replacement therapy. The patient was diagnosed with GD, which improved with antithyroid agent administration. To date, only 50 cases regarding conversion from HT to GD have been reported. The median age is 44 years (range, 23-82 years), and the median time of conversion is 7 years (range, 0.1-27 years). The male-to-female ratio of HT conversion to GD is 1:9, closer to that of regular GD (1:10) than that of general HT (1:18). All patients received thyroid hormone replacement therapy for hypothyroidism due to HT. Continuous evaluation of TSAb levels is recommended in HT, particularly in cases of TSAb-positive and those under replacement, since it may help predict conversion to GD. Evaluating the clinical characteristics of patients with HT preceding GD is crucial to ensure appropriate treatment and reduce the risk of adverse events.
Keywords: Graves’ disease; Hashimoto thyroiditis; autoimmune disease; thyroid antibodies.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Effects of block-replace regimen in patients with autoimmune hypothyroidism converted to Graves' disease.Hormones (Athens). 2024 Mar;23(1):107-111. doi: 10.1007/s42000-023-00496-w. Epub 2023 Oct 13. Hormones (Athens). 2024. PMID: 37831339 Review.
-
Hashimoto's thyroiditis following Graves' disease.Acta Med Indones. 2010 Jan;42(1):31-5. Acta Med Indones. 2010. PMID: 20305330
-
[Distribution of IgG subclasses of TgAb and TPOAb in sera from patients with Graves' disease, Graves' disease plus Hashimoto's thyroiditis and Hashimoto's thyrotoxicosis].Zhonghua Yi Xue Za Zhi. 2014 Jan 14;94(2):110-4. Zhonghua Yi Xue Za Zhi. 2014. PMID: 24721350 Chinese.
-
Graves' disease following hypothyroidism due to Hashimoto's disease: studies of eight cases.Clin Endocrinol (Oxf). 1990 Dec;33(6):687-98. doi: 10.1111/j.1365-2265.1990.tb03906.x. Clin Endocrinol (Oxf). 1990. PMID: 1982861
-
Multiple nutritional factors and thyroid disease, with particular reference to autoimmune thyroid disease.Proc Nutr Soc. 2019 Feb;78(1):34-44. doi: 10.1017/S0029665118001192. Epub 2018 Sep 13. Proc Nutr Soc. 2019. PMID: 30208979 Review.
Cited by
-
A Rare and Unusual Evolution of Hypothyroidism in Hashimoto's Thyroiditis to Graves' Disease: A Case Report and Literature Review.Cureus. 2024 Apr 26;16(4):e59059. doi: 10.7759/cureus.59059. eCollection 2024 Apr. Cureus. 2024. PMID: 38800272 Free PMC article.
-
Effects of block-replace regimen in patients with autoimmune hypothyroidism converted to Graves' disease.Hormones (Athens). 2024 Mar;23(1):107-111. doi: 10.1007/s42000-023-00496-w. Epub 2023 Oct 13. Hormones (Athens). 2024. PMID: 37831339 Review.
-
Thyroid ultrasound pattern in primary hypothyroidism is similar to Graves' disease: a report of three cases.J Med Life. 2024 Jan;17(1):116-122. doi: 10.25122/jml-2023-0507. J Med Life. 2024. PMID: 38737666 Free PMC article.
-
Association of autoimmune thyroid disease with type 1 diabetes mellitus and its ultrasonic diagnosis and management.World J Diabetes. 2024 Mar 15;15(3):348-360. doi: 10.4239/wjd.v15.i3.348. World J Diabetes. 2024. PMID: 38591076 Free PMC article. Review.
-
A Review of Testing for Distinguishing Hashimoto's Thyroiditis in the Hyperthyroid Stage and Grave's Disease.Int J Gen Med. 2023 Jun 8;16:2355-2363. doi: 10.2147/IJGM.S410640. eCollection 2023. Int J Gen Med. 2023. PMID: 37313042 Free PMC article. Review.
References
-
- Antonelli A., Ferrari S.M., Ragusa F., Elia G., Paparo S.R., Ruffilli I., Patrizio A., Giusti C., Gonnella D., Cristaudo A., et al. Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses. Best Pract. Res. Clin. Endocrinol. Metab. 2020;34:101387. doi: 10.1016/j.beem.2020.101387. - DOI - PubMed
-
- Kamijo K. TSH-receptor antibody measurement in patients with various thyrotoxicosis and Hashimoto’s thyroiditis: A comparison of two two-step assays, coated plate ELISA using porcine TSH-receptor and coated tube radioassay using human recombinant TSH-receptor. Endocr. J. 2003;50:113–116. doi: 10.1507/endocrj.50.113. - DOI - PubMed
-
- Kamath C., Young S., Kabelis K., Sanders J., Adlan M.A., Furmaniak J., Rees Smith B., Premawardhana L.D. Thyrotrophin receptor antibody characteristics in a woman with long-standing Hashimoto’s who developed Graves’ disease and pretibial myxoedema. Clin. Endocrinol. 2012;77:465–470. doi: 10.1111/j.1365-2265.2012.04397.x. - DOI - PubMed
-
- Kraiem Z., Baron E., Kahana L., Sadeh O., Sheinfeld M. Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo to hyper-thyroidism and back to hypothyroidism. Clin. Endocrinol. 1992;36:211–214. doi: 10.1111/j.1365-2265.1992.tb00960.x. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical